Cargando…
China Stroke Registry for Patients With Traditional Chinese Medicine (CASES-TCM): Rationale and Design of a Prospective, Multicenter, Observational Study
Background: Given the complexity of stroke treatment and the current widespread use of traditional Chinese medicine (TCM) in the absence of robust, large, long-term effectiveness and safety studies, and the lack of nationwide epidemiology and clinical characteristics of patients with stroke receivin...
Autores principales: | Feng, Luda, Kong, Lingbo, Dong, Xinglu, Lai, Xinxing, Zhang, Dandan, Ren, Beida, Liu, Shen, Xie, Xiaolong, Li, Chuanpeng, Song, Yuebo, Du, Yawei, Cao, Kegang, Zhang, Chi, Gao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438566/ https://www.ncbi.nlm.nih.gov/pubmed/34531755 http://dx.doi.org/10.3389/fphar.2021.743883 |
Ejemplares similares
-
Vital real-world experience regarding Naoshuantong capsules for unselected ischemic stroke (VENUS): Rationale, design, and baseline of a prospective, multicenter, observational study
por: Dong, Xinglu, et al.
Publicado: (2022) -
Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design
por: Feng, Luda, et al.
Publicado: (2021) -
Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
por: Liu, Jia, et al.
Publicado: (2022) -
Efficacy and safety of LongShengZhi capsule on functional recovery after acute ischemic stroke (LONGAN): Protocol and statistical analysis plan for a randomized, double-blind, placebo-controlled trial
por: Zhang, Dandan, et al.
Publicado: (2022) -
A minireview of the medicinal and edible insects from the traditional Chinese medicine (TCM)
por: Zhang, Enming, et al.
Publicado: (2023)